AR-709

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAR-709
Drug Alias NameAR-709
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEvolva
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvolva
Active IndicationsN/A
Inactive IndicationsRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A